Breaking News Headlines Today | Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

centerforbiosimilars.com image

News from centerforbiosimilars.com

Top centerforbiosimilars.com News

Insulin Aspart-xjhz Becomes First Interchangeable Biosimilar Rapid-Acting Insulin

United States · United States

Insulin Aspart-xjhz Becomes First Interchangeable Biosimilar Rapid-Acting Insulin

The agent, Kirsty, represents a more affordable alternative to Novolog.See the Story

3 Types of Multiple Myeloma Treatments

United States · United States

3 Types of Multiple Myeloma Treatments

Medically reviewed by Archana Sharma, DOThere are several treatment options for multiple myeloma. Since this disease varies by person, the type of therapy you receive depends on factors such as your age, general health, and disease stage.Jump to Key Takeaways.nomadnes / Getty Images The goal of multiple myeloma treatment is to control the cancer, ease symptoms, and extend life.1. Drug TherapyMost people with multiple myeloma begin treatment with…See the Story

Bevacizumab Biosimilar Fills Gap for Retinal Disease With Encouraging Safety Data

Bevacizumab Biosimilar Fills Gap for Retinal Disease With Encouraging Safety Data

Real-world data confirm Mvasi's safety as a cost-effective alternative to reference bevacizumab (Avastin) for treating retinal conditions.Read Article

Breaking News Topics Related to centerforbiosimilars.com